Literature DB >> 731022

e-Antigen: a link between immune response and infectivity in hepatitis B?

G C Turner, H T Green, V D Blundell.   

Abstract

In a study of the distribution of e-antigen and anti-e in subjects whose blood was positive for hepatitis B surface antigen (HBsAg), patients with acute hepatitis B who were tested during the incubation period were all e-antigen-positive but after the onset of illness e-antigen was detected in only 11%. Persistence, and in some instances reappearance of e-antigen in those who became long-term carriers of HBsAg was associated with high titres of HBsAg. There was a high incidence of e-antigen in those conditions in which cell-mediated immunity may be depressed, including Down's syndrome and chronic renal failure. The majority of HBsAg carries identified as sources of infection were e-antigen-positive. A postive reaction for e-antigen is evidently associated with a defective immune response to hepatitis B virus infection which permits continued replication of virus in liver cells accompanied by high titres of HBsAg, numerous Dane particles and detectable DNA polymerase in the blood with consequently a greater likelihood of transmitting infection. Although it cannot be assumed that anti-e positive carriers of HBsAg are not infective, it may be necessary, in the assessment of passive or active immunization for the control of hepatitis B, to take into account the e-antigen/antibody status of possible sources of infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731022      PMCID: PMC2130069          DOI: 10.1017/s0022172400025298

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  24 in total

1.  Dialysis-associated hepatitis: prevention and control.

Authors:  B J Hawe; H J Goldsmith; P O Jones
Journal:  Br Med J       Date:  1971-03-06

2.  Letter: E antigen: prognostic marker in acute viral hepatitis B?

Authors:  G Thamer; K Gmelin; B Kommerell
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

3.  Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.

Authors:  C Trepo; R G Bird; A J Zuckerman
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

4.  Discordant e antigen, DNA polymerase activity, and Dane particle responses in two patients representing an index case-contact case pair with hepatitis B virus infection.

Authors:  R P Perrillo; L D Gelb; W H Milligan; W Wellinghoff; R D Aach
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

5.  Subtypes of hepatitis B antigen among patients and symptomless carriers.

Authors:  H T Green; G C Turner
Journal:  J Hyg (Lond)       Date:  1975-02

6.  Incidence of HBe antigen and HBe antibody in blood-donors.

Authors:  M J Parker; R B Goudie; A G Shattock
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

7.  Correlation between fluorescent antibody detection of hepatitis B core antigen in liver biopsies and the presence of e antigen in serum.

Authors:  B L Murphy; J M Peterson; J L Smith; G L Gitnick; M O Auslander; K R Berquist; J E Maynard; R H Purcell
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

8.  Letter: Detection of e antigen by immunofluorescence in cytoplasm of hepatocytes of HBsAg carriers.

Authors:  C Trepo; L Vitvitski; R Neurath; N Hashimoto; R Schaefer; G Nemoz
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

9.  Occurrence of e antigen in acute hepatitis B.

Authors:  P E Gibson; K Ruparella
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

10.  e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.

Authors:  P E Gibson
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

View more
  1 in total

1.  The HBsAg-Positive Patient: Implications and a Guide to Management.

Authors:  R P Larke
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.